Concentra Group Holdings Parent Inc. Common Stock (CON)

FairStock Score: 67/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Concentra provides occupational health services through centers, onsite clinics, and telemedicine. I like recurring employer relationships, but the numbers require caution. In fiscal 2025, the year ended 2025-12-31, revenue was $2.2B, net income $166.4M, and diluted EPS $1.30. In fiscal 2024, the year ended 2024-12-31, revenue was $1.9B, net income $166.5M, and diluted EPS $1.46; in fiscal 2023, the year ended 2023-12-31, revenue was $1.8B, net income $179.9M, and diluted EPS $1.73. So revenue rose, but reported profit and per-share earnings declined—not the compounding I seek. Recent quarters improved: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $606.0M, net income $65.3M, and diluted EPS $0.51, versus revenue $550.8M, net income $44.6M, and diluted EPS $0.35 in the quarter ended 2025-06-30. FairStock calls it SLOW GROWER — Shrinking: profit -0.1% a year over three years, revenue 7.9%. Financial health is mixed. FairStock's Piotroski F-Score is a perfect 9/9, and trailing free cash flow is $267.4M, a 5.6% FCF yield. But debt/equity is 4.23, Altman Z-Score is 1.64, ROCE is 8.16%, and ROE of 47.06% may reflect leverage. At the 2026-10-13 close of $37.54, FairStock calculates P/E 24.22, P/B 10.04, PEG 0.52, EV/EBITDA 14.90, and Graham Number $11.42, a -228.72% margin of safety. Mr. Market is paying a full price for a business with modest long-term profit growth and heavy debt. I would demand more evidence of durable per-share gains.

In plain English: Concentra runs occupational health clinics and workplace health services. The business is profitable and produces cash, but it carries a lot of debt, and profits over the last three years have been roughly flat. The stock price looks high compared with the company's accounting value and earnings, even though recent quarterly results improved.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer